Box score
Avenzo Therapeutics, Inc.
Reported $47.2M sold in a new Form D filed September 5, 2025 (San Diego, California).
- Biggest raise
- $47.2M filed Sep 5, 2025
- League
- Bio & Health Biotechnology
- Based in
- San Diego, California
- Season rank
- #84 of 1,311 in the Bio & Health League; #503 of 12,397 overall (2025)
- Incorporated
- 2022
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-09-05 | New notice | $47.2M | $75M | SEC |
| 2024-11-20 | Amendment | $386M | $386M | SEC |
| 2024-03-26 | Amendment | $223M | $347M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1947742.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Alto Neuroscience, Inc. | Bio & Health | $50M |
| 2 | HeartFlow Holding, Inc. | Bio & Health | $48.4M |
| 3 | Solve Therapeutics, Inc. | Bio & Health | $48.2M |
| 4 | SRT Therapeutics, Inc. rookie | Bio & Health | $47.4M |
| 5 | Equip Health, Inc. | Bio & Health | $46.6M |
| 6 | Allay Therapeutics, Inc. | Bio & Health | $45M |